🇺🇸 FDA
Pipeline program

GPC3-CAR-T cells

HXYT-009

Phase 1 mab on_hold

Quick answer

GPC3-CAR-T cells for Hepatocellular Carcinoma is a Phase 1 program (mab) at Xiyuan Hospital of China Academy of Chinese Medical Sciences with 1 ClinicalTrials.gov record(s).

Program details

Company
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Indication
Hepatocellular Carcinoma
Phase
Phase 1
Modality
mab
Status
on_hold

Clinical trials